These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 193134

  • 1. Further studies on the C5-derived chemotactic factor for tumor cells.
    Romualdez AG, Ward PA.
    Prog Clin Biol Res; 1976; 9():65-71. PubMed ID: 193134
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.
    Orr W, Varani J, Ward PA.
    Am J Pathol; 1978 Nov; 93(2):405-22. PubMed ID: 568888
    [Abstract] [Full Text] [Related]

  • 3. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
    Orr FW, Varani J, Kreutzer DL, Senior RM, Ward PA.
    Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
    [Abstract] [Full Text] [Related]

  • 4. Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.
    Romualdez AG, Ward PA, Torikata T.
    J Immunol; 1976 Nov; 117(5 Pt.2):1762-6. PubMed ID: 62790
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antileukotactic properties of tumor cells.
    Brozna JP, Ward PA.
    J Clin Invest; 1975 Sep; 56(3):616-23. PubMed ID: 239965
    [Abstract] [Full Text] [Related]

  • 7. Effects of passage, growth phase, and heterogeneity of a tumor cell population on tumor cell chemotaxis.
    Oda D, Orr FW.
    Invasion Metastasis; 1984 Sep; 4(4):189-97. PubMed ID: 6533092
    [Abstract] [Full Text] [Related]

  • 8. The effect of a novel C5 inhibitor (K-76 COONa) on tumor cell chemotaxis.
    Bumpers HL, Baum J.
    J Lab Clin Med; 1983 Sep; 102(3):421-7. PubMed ID: 6886523
    [Abstract] [Full Text] [Related]

  • 9. Generation of a complement-derived chemotactic factor for tumor cells in experimentally induced peritoneal exudates and its effect on the local metastasis of circulating tumor cells.
    Orr FW, Mokashi S, Delikatny J.
    Am J Pathol; 1982 Jul; 108(1):112-8. PubMed ID: 7091299
    [Abstract] [Full Text] [Related]

  • 10. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA, Klebanoff SJ.
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Generation of a fibroblast chemotactic factor in serum by activation of complement.
    Postlethwaite AE, Snyderman R, Kang AH.
    J Clin Invest; 1979 Nov; 64(5):1379-85. PubMed ID: 91624
    [Abstract] [Full Text] [Related]

  • 13. Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5.
    Orr W, Phan SH, Varani J, Ward PA, Kreutzer DL, Webster RO, Henson PM.
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1986-9. PubMed ID: 287038
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation.
    Muhlfelder TW, Niemetz J, Kreutzer D, Beebe D, Ward PA, Rosenfeld SI.
    J Clin Invest; 1979 Jan; 63(1):147-50. PubMed ID: 762243
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.